In the future, we are intrigued by the prospect of substantiating our findings through validation in human cancer cell lines associated with hyperactivated IIS or Ras activity, such as cutaneous melanoma and certain types of leukemias, among many other human malignancies [20,21,33]. The gene discussed is SCGB1D4; the disease is leukemia.